110 related articles for article (PubMed ID: 24825983)
21. Antitumor agents. 213. Modeling of epipodophyllotoxin derivatives using variable selection k nearest neighbor QSAR method.
Xiao Z; Xiao YD; Feng J; Golbraikh A; Tropsha A; Lee KH
J Med Chem; 2002 May; 45(11):2294-309. PubMed ID: 12014968
[TBL] [Abstract][Full Text] [Related]
22. Towards predictive inhibitor design for the EGFR autophosphorylation activity.
San Juan AA
Eur J Med Chem; 2008 Apr; 43(4):781-91. PubMed ID: 17689836
[TBL] [Abstract][Full Text] [Related]
23. In silico QSAR studies of anilinoquinolines as EGFR inhibitors.
Pasha FA; Muddassar M; Srivastava AK; Cho SJ
J Mol Model; 2010 Feb; 16(2):263-77. PubMed ID: 19590909
[TBL] [Abstract][Full Text] [Related]
24. Discovery of Potent Antihypertensive Ligands Substituted Imidazolyl Biphenyl Sulfonylureas Analogs as Angiotensin II AT1 Receptor Antagonists by Molecular Modelling Studies.
Sharma MC
Interdiscip Sci; 2015 Sep; 7(3):221-32. PubMed ID: 26188391
[TBL] [Abstract][Full Text] [Related]
25. 3D-QSAR and molecular docking studies of 4-anilinoquinazoline derivatives: a rational approach to anticancer drug design.
Nandi S; Bagchi MC
Mol Divers; 2010 Feb; 14(1):27-38. PubMed ID: 19330460
[TBL] [Abstract][Full Text] [Related]
26. 3D-QSAR studies on CCR2B receptor antagonists: Insight into the structural requirements of (R)-3-aminopyrrolidine series of molecules based on CoMFA/CoMSIA models.
Gade S; Mahmood S
J Pharm Bioallied Sci; 2012 Apr; 4(2):123-33. PubMed ID: 22557923
[TBL] [Abstract][Full Text] [Related]
27. Receptor-guided alignment-based comparative 3D-QSAR studies of benzylidene malonitrile tyrphostins as EGFR and HER-2 kinase inhibitors.
Kamath S; Buolamwini JK
J Med Chem; 2003 Oct; 46(22):4657-68. PubMed ID: 14561085
[TBL] [Abstract][Full Text] [Related]
28. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
Bhongade BA; Gadad AK
J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
[TBL] [Abstract][Full Text] [Related]
29. 3D-QSAR and Molecular Docking Studies on Oxadiazole Substituted Benzimidazole Derivatives: Validation of Experimental Inhibitory Potencies Towards COX-2.
Asati V; Ghode P; Bajaj S; Jain SK; Bharti SK
Curr Comput Aided Drug Des; 2019; 15(4):277-293. PubMed ID: 30280671
[TBL] [Abstract][Full Text] [Related]
30. 3D-QSAR Studies on a Series of 5-Arylidine-2, 4-Thiazolidinediones as Aldose Reductase Inhibitors: A Self-Organizing Molecular Field Analysis Approach.
Thareja S; Aggarwal S; Bhardwaj TR; Kumar M
Med Chem; 2010 Mar; ():. PubMed ID: 20218967
[TBL] [Abstract][Full Text] [Related]
31. 3D-QSAR and docking studies on 4-anilinoquinazoline and 4-anilinoquinoline epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors.
Assefa H; Kamath S; Buolamwini JK
J Comput Aided Mol Des; 2003 Aug; 17(8):475-93. PubMed ID: 14703120
[TBL] [Abstract][Full Text] [Related]
32. P56(lck) kinase inhibitor studies: a 3D QSAR approach towards designing new drugs from flavonoid derivatives.
Gunda SK; Narasimha SK; Shaik M
Int J Comput Biol Drug Des; 2014; 7(2-3):278-94. PubMed ID: 24878734
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and biological evaluation of 1,3,4-oxadiazole derivatives.
Jha KK; Samad A; Kumar Y; Shaharyar M; Khosa RL; Jain J; Kumar V; Singh P
Eur J Med Chem; 2010 Nov; 45(11):4963-7. PubMed ID: 20817328
[TBL] [Abstract][Full Text] [Related]
34. New Research for Quinazoline-2,4-diones as HPPD Inhibitors Based on 2D-MLR and 3D-QSAR Models.
Fu Y; Sun YN; Cao HF; Yi KH; Zhao LX; Li JZ; Ye F
Comb Chem High Throughput Screen; 2017; 20(9):748-759. PubMed ID: 28637410
[TBL] [Abstract][Full Text] [Related]
35. 2D, 3D-QSAR and docking studies of 1,2,3-thiadiazole thioacetanilides analogues as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
Jain SV; Ghate M; Bhadoriya KS; Bari SB; Chaudhari A; Borse JS
Org Med Chem Lett; 2012 Jun; 2(1):22. PubMed ID: 22691718
[TBL] [Abstract][Full Text] [Related]
36. QSAR studies on 3-(4-biphenylmethyl) 4, 5-dihydro-4-oxo-3H-imidazo [4, 5-c] Pyridine derivatives as angiotensin II (AT1) receptor antagonist.
Sharma MC
Interdiscip Sci; 2015 Jun; 7(2):113-28. PubMed ID: 26215494
[TBL] [Abstract][Full Text] [Related]
37. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W
Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834
[TBL] [Abstract][Full Text] [Related]
38. In silico evaluation, molecular docking and QSAR analysis of quinazoline-based EGFR-T790M inhibitors.
Asadollahi-Baboli M
Mol Divers; 2016 Aug; 20(3):729-39. PubMed ID: 27209475
[TBL] [Abstract][Full Text] [Related]
39. A comparative QSAR analysis of quinazoline analogues as tyrosine kinase (erbB-2) inhibitors.
Noolvi MN; Patel HM; Bhardwaj V
Med Chem; 2011 May; 7(3):200-12. PubMed ID: 21486203
[TBL] [Abstract][Full Text] [Related]
40. 3D-QSAR study on a series of Bcl-2 protein inhibitors using comparative molecular field analysis.
Hou X; Du J; Fang H; Li M
Protein Pept Lett; 2011 May; 18(5):440-9. PubMed ID: 21171944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
